IFNB1 and adenoviridae infectious disease: KO of TRIM29 enhanced production of IFN-β and IFN-α in BMDCs in response to HSV-1 or adenovirus infection twofold to fourfold at 6, 12, or 20 h post infection (Fig. 3f and Supplementary Fig. 6a).